Mon, Jul 28, 2014, 10:39 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Novadaq Technologies Inc. Message Board

  • bigken17@ymail.com bigken17 Nov 2, 2012 8:53 AM Flag

    Looks very interesting

    Time frame is a bit beyond my understanding, but the concept of the product seems to have a very large impact if they can get it widely placed anyone know anything I'm very interested in this stock!

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • #$%$????

    • andersongordon@ymail.com andersongordon Nov 2, 2012 11:54 AM Flag

      Currently this new technology is being marketed by two leading companies Life Cell and Intuitive Surgical. They are in the initial stages of roll-out. Less than 2 years for a new technology that is a game changer for surgeons, hospitals, medical insurance and patients. All win with this new technology. A typical adoption curve looks like an "S" curve (sigmoidal function for math wonks). The adoption starts very slowly with first time users and thought leader (surgeons). Once adoption gets to around 15-20% it takes off very rapidly. With Life Cell (breast reconstruction) they are currently at 11% adoption rate and are increasing around 1% per quarter. My modelling show positive earnings 2 or 3 quarters away. This was also aluded to in the conference call. The two big 500 pound gorillas in the room are "Pinpoint" and LUNA's diabetic and wound treatment potential. Both are in the pre-commertial phase. To put things in perspective the current Life Cell and Intuitive markets are around 160k proceedures per year versus 6000+k for these two new ventures. Enjoy the ride.

      GSA

      Sentiment: Strong Buy

      • 1 Reply to andersongordon
      • GSA - You nailed it - if someone was only looking at the initial LifeCell and Intuitive markets, there may be an argument for this stock being a bit ahead of itself on valuation. The Pinpoint and KCI/wound care market opportunities dwarf the LifeCell and Intuitive markets and adoption should be more rapid. 2013 will still be about LifeCell and Intuitive, but 2014 will take the growth curve to a whole new level - it will be quite a ride.

    • They lost 23 cents for the quarter and have never made a PROFIT

 
NVDQ
16.56-0.20(-1.19%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.